J Rheum Dis.  2011 Jun;18(2):132-136.

Two Cases of Necrotizing Fasciitis in Patients with SLE

Affiliations
  • 1Division of Rheumatology, Gachon University of Medicine and Science, Incheon, Korea. hjchoi@gachon.ac.kr
  • 2Division of Rheumatology, Seoul National University Hospital, Seoul, Korea.

Abstract

Necrotizing fasciitis (NF) is an uncommon, life-threatening infection of the subcutaneous tissue and superficial fascia. The clinical course of NF is rapid and progressive, and it is often fatal despite the appropriate therapy. The prognosis of NF depends on a timely diagnosis and then proper treatment. At onset it may not be possible to clearly distinguish NF from minor soft-tissue infections. Although infection are common due to the use of steroids and immunosuppressive agents in patients with systemic lupus erythematous (SLE), it is interesting that NF has rarely been reported with SLE. Here, we present two cases of NF with SLE.

Keyword

Necrotizing fascitis; SLE

MeSH Terms

Fasciitis, Necrotizing
Humans
Immunosuppressive Agents
Prognosis
Steroids
Subcutaneous Tissue
Immunosuppressive Agents
Steroids

Figure

  • Figure 1. There are edematous changes and skin color changes on the right lower leg.

  • Figure 2. A hypointensive signal is seen in the anterior, lateral and posterior compartments (Right lower leg T1 image: A, white arrow). Thickening and enhanced fasciitis lesion is seen in the anterior, lateral and posterior compartments (T2 image: B, black arrow). Edematous change and enhanced myositis is seen in the tibialis anterior muscle (white arrow) and the extensor digitorum muscle (black arrow) (T2 image: C).


Reference

References

1. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. European Working Party on Systemic Lupus Erythematosus. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore). 2003; 82:299–308.
2. Iliopoulos AG, Tsokos GC. Immunopathogenesis and spectrum of infections in systemic lupus erythematosus. Semin Arthritis Rheum. 1996; 25:318–36.
3. Zonana-Nacach A, Camargo-Coronel A, Yañez P, Sánchez L, Jimenez-Balderas FJ, Fraga A. Infections in outpatients with systemic lupus erythematosus: a prospective study. Lupus. 2001; 10:505–10.
Article
4. Hasham S, Matteucci P, Stanley PR, Hart NB. Necrotising fasciitis. BMJ. 2005; 330:830–3.
Article
5. Wong CH, Chang HC, Pasupathy S, Khin LW, Tan JL, Low CO. Necrotizing fasciitis: clinical presentation, mi-crobiology, and determinants of mortality. J Bone Joint Surg Am. 2003; 85-A:1454–60.
6. Chong JH, Yoo WH. Necrotizing fasciitis in a patient with overlap syndrome of systemic sclerosis and systemic lupus erythematosus. Rheumatol Int. 2009; [Epub ahead of print].
Article
7. Lee MW, Kim TH, Choo EJ, Kang JH, Kim DW, Kim DK, et al. Characteristics of necrotizing fasciitis in three university hospitals in Korea. Korean J Med. 2006; 70:681–7.
8. Mok MY, Wong SY, Chan TM, Tang WM, Wong WS, Lau CS. Necrotizing fasciitis in rheumatic diseases. Lupus. 2006; 15:380–3.
Article
9. Isik A, Koca SS. Necrotizing fasciitis resulting from Streptococcus pneumoniae in recently diagnosed systemic lupus erythematosus case: a case report. Clin Rheumatol. 2007; 26:999–1001.
Article
10. Son GS, Choi IS, Kim KH, Jung KH, Hong YS. MRI for the early diagnosis of necrotizing fasciitis. J Korean Surg Soc. 1997; 52:766–70.
11. Seok JH, Jee WH, Chun KA, Kim JY, Jung CK, Kim YR, et al. Necrotizing fasciitis versus pyomyositis: dis-crimination with using MR imaging. Korean J Radiol. 2009; 10:121–8.
Article
12. Kamran M, Wachs J, Putterman C. Necrotizing fasciitis in systemic lupus erythematosus. Semin Arthritis Rheum. 2008; 37:236–42.
Article
13. Hwang JE, Woo H, Kim SH, Lee WS, Hwang JH, Kim JC, et al. Successful treatment of necrotizing fasciitis in a patient with rheumatoid arthritis. J Korean Rheum Assoc. 2006; 13:155–9.
14. Hashimoto N, Sugiyama H, Asagoe K, Hara K, Yamasaki O, Yamasaki Y, et al. Fulminant necrotising fasciitis developing during longterm corticosteroid treatment of systemic lupus erythematosus. Ann Rheum Dis. 2002; 61:848–9.
Full Text Links
  • JRD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr